ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences

BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows: H.C. Wainwright Global Investment Conference (Virtual)     Date: Tuesday, May 24, 2022     Time: On Demand, 7:00 a.m. ET   … [Read more…]

Global RNA Based Therapeutic Market to 2027 – Rising Popularity of Personalized Medicines is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global RNA Based Therapeutic Market By Type, By Application, By End User, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The Global RNA Based Therapeutic Market size is expected to reach $11.4 billion by 2027, rising at a market growth of 15.1 % CAGR during … [Read more…]

Global Osteoporosis Therapeutics Market to 2027 – Rising Prevalence of Osteoporosis in Post-menopausal Women Propels Market Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Osteoporosis Therapeutics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The global market for Osteoporosis Therapeutics estimated at US$11.5 Billion in the year 2020, is projected to reach a revised size of US$14 Billion by 2027, growing at a CAGR of 2.8% over the analysis period 2020-2027. Bisphosphonates, … [Read more…]

Global Proliferative Vitreoretinopathy (PVR) Drugs Pipeline Guide 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Proliferative Vitreoretinopathy (PVR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. The pipeline guide provides an overview of the Proliferative Vitreoretinopathy (PVR) (Ophthalmology) pipeline landscape. It provides comprehensive information on the therapeutics under development for Proliferative Vitreoretinopathy, complete with … [Read more…]

Athersys Announces That Its Partner, HEALIOS K.K., Reported Topline Data From the TREASURE Multistem Ischemic Stroke Study

TREASURE topline results show evidence of therapeutic impact Study preliminary results analyses indicate good potential for favorable results in Athersys’ MASTERS-2 study Conference call today at 8:30 a.m. ET CLEVELAND, Ohio–(BUSINESS WIRE)–$ATHX #Athersys–Athersys, Inc. (Nasdaq: ATHX) announced today that its partner, HEALIOS K.K. (Healios), has reported topline results for its Japan ischemic stroke study, TREASURE. … [Read more…]

Sleepio Is the First-Ever Digital Therapeutic to Receive NICE Guidance, Confirming Clinical and Cost Effectiveness

LONDON–(BUSINESS WIRE)–Big Health has become the first digital therapeutics company to receive guidance from the National Institute for Health and Care Excellence (NICE), which has recommended Sleepio as a cost-saving option for treating insomnia in a move that heralds a new era in digital medicine. The NICE guidance states that Sleepio, Big Health’s digital therapeutic … [Read more…]

Harm Reduction Policies Key to Improve Europeans’ Health

BRUSSELS–(BUSINESS WIRE)–Yesterday, the Platform for Better Preventive Healthcare organised a policy briefing “What are the next steps for the EU addictions policy”, hosted by Czech Member of the European Parliament (MEP) Radka Maxová (Socialists and Democrats). The briefing gathered healthcare experts and political stakeholders to discuss the Report of the Special Committee on Beating Cancer … [Read more…]

medZERO Continues to Sign up Innovative Companies Wanting to Offer Expanded Benefits to Attract and Retain Employees in Competitive Market

PORTLAND, Ore.–(BUSINESS WIRE)–#healthcare–In the race to retain employees in a competitive market, medZERO’s innovative app-based healthcare funding solution is an increasingly attractive add-on benefit for employers. “In this competitive job market, we want to do everything we can to attract and retain the best employees,” said Candace Atnip, Chief People Officer for Bamboo Sushi. “medZERO’s … [Read more…]

CANbridge Pharmaceuticals to Participate in the Morgan Stanley Virtual China Summit 2022

BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, today announced that it will participate in the Morgan Stanley Virtual China Summit 2022 to be held on May 24-26, 2022. About CANbridge Pharmaceuticals Inc. CANbridge Pharmaceuticals … [Read more…]

Sonendo, Inc. to Present at the Stifel Jaws and Paws Conference

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will be participating in the upcoming Stifel Jaws and Paws Conference. Bjarne Bergheim, President & Chief Executive Officer, and Michael Watts, Chief Financial Officer, are scheduled to present on Wednesday, June 1 at … [Read more…]